PF-04634817 Renal Impairment Study
NCT01791855
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Insufficiency
Interventions
DRUG:
PF-04634817
DRUG:
PF-04634817
DRUG:
PF-04634817
DRUG:
PF-04634817
Sponsor
Pfizer